QS Investors’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $1.23M | Sell |
5,764
-27
| -0.5% | -$5.7K | 0.01% | 440 |
|
|
2021
Q1 | $1.18M | Hold |
5,791
| – | – | 0.01% | 482 |
|
|
2020
Q4 | $1.05M | Sell |
5,791
-188
| -3% | -$32K | 0.01% | 485 |
|
|
2020
Q3 | $1M | Sell |
5,979
-180
| -3% | -$30.3K | 0.01% | 445 |
|
|
2020
Q2 | $1M | Sell |
6,159
-31
| -0.5% | -$5.56K | 0.01% | 718 |
|
|
2020
Q1 | $1.07M | Buy |
6,190
+10
| +0.2% | +$1.99K | 0.02% | 641 |
|
|
2019
Q4 | $1.25M | Buy |
6,180
+410
| +7% | +$84.1K | 0.01% | 721 |
|
|
2019
Q3 | $1.22M | Sell |
5,770
-400
| -6% | -$83.6K | 0.01% | 720 |
|
|
2019
Q2 | $1.2M | Sell |
6,170
-1,100
| -15% | -$203K | 0.01% | 747 |
|
|
2019
Q1 | $1.2M | Sell |
7,270
-16
| -0.2% | -$2.83K | 0.01% | 762 |
|
|
2018
Q4 | $1.37M | Hold |
7,286
| – | – | 0.02% | 679 |
|
|
2018
Q3 | $1.24M | Hold |
7,286
| – | – | 0.01% | 763 |
|
|
2018
Q2 | $1.19M | Sell |
7,286
-7
| -0.1% | -$1.14K | 0.01% | 744 |
|
|
2018
Q1 | $1.18M | Hold |
7,293
| – | – | 0.01% | 747 |
|
|
2017
Q4 | $1.06M | Hold |
7,293
| – | – | 0.01% | 790 |
|
|
2017
Q3 | $990K | Sell |
7,293
-540
| -7% | -$68.2K | 0.01% | 810 |
|
|
2017
Q2 | $981K | Buy |
7,833
+706
| +10% | +$84.4K | 0.01% | 787 |
|
|
2017
Q1 | $847K | Sell |
7,127
-100
| -1% | -$12K | 0.01% | 828 |
|
|
2016
Q4 | $834K | Sell |
7,227
-132,795
| -95% | -$14.8M | 0.01% | 792 |
|
|
2016
Q3 | $14.6M | Sell |
140,022
-4,385
| -3% | -$458K | 0.11% | 140 |
|
|
2016
Q2 | $14.1M | Buy |
144,407
+69,309
| +92% | +$6.55M | 0.12% | 151 |
|
|
2016
Q1 | $7.21M | Buy |
75,098
+15,203
| +25% | +$1.38M | 0.07% | 275 |
|
|
2015
Q4 | $5.43M | Buy |
59,895
+15,943
| +36% | +$1.5M | 0.05% | 364 |
|
|
2015
Q3 | $4.08M | Buy |
43,952
+37,300
| +561% | +$3.55M | 0.04% | 429 |
|
|
2015
Q2 | $619K | Sell |
6,652
-158,090
| -96% | -$14.7M | 0.01% | 847 |
|
|
2015
Q1 | $15.6M | Buy |
164,742
+121,190
| +278% | +$11.2M | 0.18% | 130 |
|
|
2014
Q4 | $3.86M | Buy |
43,552
+33,000
| +313% | +$2.8M | 0.04% | 427 |
|
|
2014
Q3 | $844K | Sell |
10,552
-2,200
| -17% | -$166K | 0.02% | 378 |
|
|
2014
Q2 | $905K | Buy |
12,752
+2,852
| +29% | +$201K | 0.02% | 400 |
|
|
2014
Q1 | $732K | Buy |
9,900
+1,600
| +19% | +$121K | 0.02% | 402 |
|
|
2013
Q4 | $651K | Buy |
8,300
+2,850
| +52% | +$223K | 0.02% | 390 |
|
|
2013
Q3 | $403K | Sell |
5,450
-13,900
| -72% | -$1.02M | 0.02% | 455 |
|
|
2013
Q2 | $1.48M | Buy |
+19,350
| New | +$1.27M | 0.05% | 324 |
|
Other funds holding CME
QS Investors's CME Position: Q2 2021 in Review
QS Investors reduced its CME Group (CME) stake by 0.47% in Q2 2021, selling an estimated $5.7K and leaving 5,764 shares worth $1.23M. The position accounts for 0.01% of the portfolio, ranked #440.
QS Investors first reported a position in CME in Q2 2013 and has held it in 33 quarters since. The position peaked at $15.6M in Q1 2015. 1,086 funds tracked by Wall St. Rank hold CME as of Q2 2021.
- QS Investors held 5,764 shares of CME Group worth $1.23M as of Q2 2021.
- QS Investors sold 27 CME Group shares in Q2 2021, an estimated $5.7K.
- CME Group made up 0.01% of QS Investors's portfolio in Q2 2021, its #440 holding.
- QS Investors first reported a position in CME Group in Q2 2013 and has held it in 33 quarters since.
- QS Investors's CME Group position peaked at $15.6M in Q1 2015.
- 1,086 funds tracked by Wall St. Rank held CME Group as of Q2 2021.
Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.